Zhujiang Hospital
Clinical trials sponsored by Zhujiang Hospital, explained in plain language.
-
ICU dialysis: which dose of blood thinner works best?
Disease control Recruiting nowThis study compares two starting doses (20 mg/h vs. 50 mg/h) of the blood thinner nafamostat in ICU patients receiving continuous kidney dialysis. The goal is to see which dose keeps the dialysis filter from clotting longer while avoiding dangerous bleeding. About 92 adults will …
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Gut bacteria may supercharge lung cancer therapy
Disease control Recruiting nowThis study tests whether taking a daily probiotic (Lactobacillus rhamnosus LR607) for three months can make standard chemoimmunotherapy work better for people with stage IIB-IIIB non-small cell lung cancer before they have surgery. About 46 adults will take the probiotic alongsid…
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug aims to fix anemia after stem cell transplants
Disease control Recruiting nowThis early study tests a drug called luspatercept (Reblozyl) to treat anemia in 46 people with acute leukemia who have had a stem cell transplant. The drug is given as a shot one and four weeks after transplant. The main goal is to see if it raises hemoglobin levels and reduces t…
Phase: PHASE1, PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo aims to stop leukemia return after transplant
Disease control Recruiting nowThis study is testing whether a combination of two drugs—azacitidine (given as a shot) and chidamide (taken as a pill)—can safely prevent high-risk acute myeloid leukemia from coming back after a stem cell transplant. About 20 adults aged 18 to 60 will receive six cycles of azaci…
Phase: PHASE1, PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New combo therapy aims to stop liver cancer recurrence in High-Risk patients
Disease control Recruiting nowThis study tests whether combining a liver-directed procedure (TACE) with the drug icaritin can help prevent liver cancer from coming back after surgery in patients at high risk of recurrence. Thirty adults who had their liver cancer completely removed will receive up to 4 TACE t…
Phase: PHASE2, PHASE3 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Blood test may spot liver cancer recurrence before scans do
Diagnosis Recruiting nowThis study is testing whether a blood test that looks for tiny bits of tumor DNA (called ctDNA) can predict if liver cancer will come back after surgery. Researchers will follow 255 patients for two years, taking blood samples regularly to see if the test detects recurrence earli…
Sponsor: Zhujiang Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
AI takes on kidney biopsies: could it Out-Diagnose doctors?
Diagnosis Recruiting nowThis study is testing an artificial intelligence model that reads kidney biopsy images to diagnose chronic kidney disease. Researchers will compare the AI's results to the standard diagnosis made by pathologists. About 2,900 patients with chronic glomerulonephritis will participa…
Sponsor: Zhujiang Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Could a zapping helmet wake the unresponsive?
Symptom relief Recruiting nowThis study tests a new, non-invasive brain stimulation method called theta-burst patterned temporal interference stimulation (tTIs) to see if it can improve awareness in people with disorders of consciousness, such as vegetative or minimally conscious states. About 136 adults wil…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New sedative may cut ventilator time for ICU patients
Symptom relief Recruiting nowThis study compares two sedatives—remimazolam and midazolam—in 440 critically ill patients on breathing machines. The goal is to see if remimazolam helps patients come off the ventilator faster. Participants are randomly assigned to one drug, and researchers track how long they n…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Ear-Zap hope: new device may spark awakening in Brain-Injured patients
Symptom relief Recruiting nowThis study explores whether a safe, non-invasive device that stimulates a nerve in the ear can improve consciousness in people who are in a vegetative or minimally conscious state after a severe brain injury. Twenty participants will receive the stimulation twice daily for 10 day…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Mouth bacteria may predict cancer treatment success
Knowledge-focused Recruiting nowThis study looks at how the community of bacteria in the mouth changes in 32 people with advanced oral cancer after they receive a combination of chemotherapy and immunotherapy. Researchers want to see if these bacterial shifts relate to how well the tumor shrinks and to long-ter…
Sponsor: Zhujiang Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC